The optimal preoperative evaluation of cardiac risk in patients with peripheral vascular disease is controversial. In developing a paradigm for preoperative cardiac workup, potential adverse effects of evaluation and cardiac intervention must be considered. This study analyzed the deleterious outcomes of extensive, comprehensive cardiac evaluation and intervention before planned vascular surgery in patients treated at the Denver Department of Veterans Affairs Medical Center.
Introduction
Coronary artery disease (CAD) remains the principal cause of both early and late mortality after peripheral vascular reconstruction, despite improvements in anesthetic techniques and patient management. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] The greater cardiac risk in patients undergoing vascular operations compared with those having other non-cardiac surgery is in large part related to the diffuse nature of atherosclerosis and to the masking of symptoms from CAD because of limitations in activity imposed by peripheral arterial disease (PAD). Two decades ago, Hertzer and colleagues firmly established the frequent association of CAD and PAD; routine coronary angiograms in 1000 consecutive peripheral vascular patients revealed severe-correctable or severe-inoperable CAD in 36% of patients with aortic aneurysms, 28% of those with lower extremity ischemia, and 32% of those with cerebrovascular disease. 12 Remarkably, only 85 (8%) of these 1000 patients had normal coronary arteries.
Such sobering statistics have led to a myriad of strategies to identify patients at high risk for adverse cardiac outcomes. Many algorithms have been proposed combining clinical risk indices, 11, [13] [14] [15] [16] [17] exercise treadmill testing (ETT), [18] [19] [20] ambulatory electrocardiography (Holter monitoring), 4, 6, 21, 22 radionuclide ventriculography (RNVG), 23, 24 dipyridamole thallium scintigraphy (DTS), [25] [26] [27] [28] [29] dobutamine stress echocardiography, 30, 31 and coronary angiography. 7, 12 This vast array of tests and the multiple proposals for employing them indicates the absence of a consensus on the optimal approach for risk stratification in patients with PAD.
Equally controversial is what to do when severe, cor-rectable CAD is identified by preoperative tests. Advocates of coronary revascularization prior to peripheral vascular operations contend that it both enhances the safety of the vascular procedure and prolongs life expectancy in these patients. Several large retrospective studies have suggested that decreased cardiac morbidity can be achieved by prophylactic coronary artery bypass grafting (CABG). 7, 12, [32] [33] [34] [35] Few data are available regarding the value of prophylactic percutaneous transluminal coronary angioplasty (PTCA) in this setting. 36 However, prophylactic CABG or PTCA are expensive and associated with substantial morbidity and mortality, leading some to caution against their use. 37 Authorities who have recommended specific strategies for prevention of cardiac morbidity after vascular surgery generally have based their opinions on specific protocols designed to address this dilemma. In practice, decisions regarding cardiac workup and subsequent intervention are rarely standardized. Instead, the management plan is arrived at by a variable combination of cardiologists, anesthesiologists, and surgeons. Occasionally, anesthesiologists refuse to administer anesthesia to patients unless they are first 'cleared by cardiology', as if the imprimatur of a cardiologist confers a guarantee that adverse events will be avoided.
The purpose of this study was to examine the outcome of such a non-standardized approach to the cardiac evaluation and treatment of vascular patients. We were particularly interested in (1) the time required to accomplish both the cardiac evaluation and the vascular intervention;
(2) the number of patients who refused vascular surgery after cardiac evaluation/interventions; and (3) the morbidity of extended cardiac evaluations leading to CABG and PTCA in this select group of patients.
Methods

Patients
Over a consecutive 12-month period from June 1994 through June 1995, all patients considered for major operative treatment of peripheral atherosclerotic occlusive or aneurysmal disease or both during this interval were included in this review. Patients requiring emergency operations, minor procedures, amputations or those with non-atherosclerotic arterial disease were excluded.
All patients considered for surgery had a clinical evaluation, which included a routine history and physical examination, recording of all pertinent clinical characteristics and coding of findings using criteria adapted from the guidelines of the Coronary Artery Surgery Study. 38 A standard 12-lead ECG and chest roentgenogram were obtained in all patients. Previous myocardial infarction (MI) was diagnosed on the basis of the patient's history or from ECG evidence of MI.
Extended cardiac evaluation
Clinical decisions concerning additional tests were not defined by protocol. Extended cardiac evaluation consisted of the standard studies listed above plus one or more of the following: estimation of cardiac output by echocardiography or RNVG; dipyridamole thallium scintigraphy; and cardiac catheterization (CC). Extended cardiac evaluations were requested most frequently by the anesthesiology ser-Vascular Medicine 2000; 5: 3-9 vice (75%); the internal medicine service initiated extended cardiac evaluations in 15% of patients, and the vascular surgery service asked for the workup in 10%. These tests were performed and interpreted according to previously established methods. 39, 40 The time interval for extended cardiac evaluation was measured from the first clinical examination to the time of cardiac intervention (CABG or PTCA). The time from cardiology consultation to the operation for the vascular disorder was also determined provided that vascular surgery was eventually performed.
Review of clinical characteristics
Each patient's medical record was reviewed to determine the presence/status of the following variables: age, sex, indication for operation, hemodynamic or anatomic data (e.g. ankle/brachial indices, aneurysm size, per cent carotid artery stenosis), smoking status, presence of diabetes, presence of hypertension, and history of CAD and/or CHF, previous CABG or PTCA. Results of standard and extended cardiac tests were recorded. Mean values were expressed with standard deviations.
Main outcome measures
The time required to accomplish both cardiac evaluation and vascular intervention was recorded. Patients who underwent cardiac evaluations but subsequently refused vascular surgery were enumerated and analyzed. All standard complications directly related to coronary angiography such as major contrast reactions, pseudoaneurysms, emboli, and excessive blood loss were determined. Mortality, nonfatal MI from CC and CABG/PTCA were assessed.
Results
Characteristics of the patients
During the study period, 771 patients were referred to the vascular surgery service for evaluation and treatment; from these patients 161 major arterial operations were recommended and 153 were performed. The 153 arterial reconstructions consisted of procedures for aortic disease (aneurysmal and occlusive) (34%), lower extremity occlusive disease (35%), and cerebrovascular disease (31%). Forty-two patients (27%) underwent extended preoperative cardiac evaluations. All of these patients were men, ranging in age from 46 to 81 years (mean 68 Ϯ 9 years). A total of 17% of these patients had diabetes, 67% had hypertension, and 38% were current smokers. Table 1 summarizes and compares the demographic features of the study patients and those who proceeded to have vascular operations without an extended cardiac evaluation. Clinical evidence of CAD (symptoms of angina, history of congestive heart failure, treatment for arrhythmias, previous MI, abnormal ECG, previous CABG or PTCA) was present in 32 of the 42 (76%). In these 32 patients, extended cardiac evaluations were undertaken for an abnormal ECG or angina pectoris in 16 (50%), whereas 16 (50%) patients had a combination of congestive heart failure, diabetes, age Ͼ70, etc. Of note, 10 of the 42 study patients who had extended cardiac evaluations had no clinical evidence of CAD, but had one or more risk factors for this disorder. 27 The details of the CAD history, symptoms and examination findings are shown in Table 2 . 27 A total of 17% of patients had a CC without a preliminary screening test. The findings of the coronary evaluations are shown in Table 2 .
The time required for the extended cardiac workup ranged from 1 to 330 days (median 14 days; mean 30 Ϯ 59 days). This long interval was related to difficulties in scheduling DTS and cardiology clinic appointments, the multiple tests performed in many patients, and the large geographical area served by the Denver VAMC such that many patients resided in outlying communities long distances from the medical center and had difficulties in arranging transportation.
Interventions for CAD in these 42 patients consisted of PTCA in nine (21%) and CABG in seven (17%). The time elapsed from the beginning of the extended cardiac evaluation to the vascular operation, including recovery time after PTCA or CABG, ranged from 2 to 365 days (median 25 days; mean 76 Ϯ 142 days).
Complications of the extended cardiac evaluation
Sixteen (38%) patients had adverse events indirectly or directly related to their extended cardiac evaluations (Table  3) . Eight patients (19%) refused to undergo the vascular operations -for which the cardiac workup was undertaken. One of these patients had symptomatic cerebrovascular disease with an internal carotid artery stenosis measuring 70%. Seven patients had abdominal aortic aneurysms (AAAs); the maximum diameter of these AAAs measured from 4.0 cm to 6.6 cm (mean 4.9 cm). Of the eight patients who refused vascular surgery, six had CC; four had PTCA; and three had CABG. Patients described many reasons for refusing the intended vascular operation, but discomfort from the intervention was most frequently cited. None of these patients went elsewhere for their vascular surgical procedures. Two patients presented with severe lower extremity ischemia. Preoperative cardiac evaluation was demanded by the anesthesia service. Both patients presented with ischemic rest pain and foot ulcers and had unrecordable ankle pressures in the affected extremity. Cardiac evaluation consisted of echocardiography, DTS, and CC. Both patients had pre-existent renal insufficiency due to diabetes mellitus, and both sustained a period of anuric renal failure requiring hemodialysis for several weeks. Although these patients were monitored daily by the vascular surgery service, electrolyte abnormalities, frequent dialyses, and hemodynamic instability associated with dialysis precluded the infrainguinal reconstructions planned for these patients. During this period gangrenous changes in the extremities of both patients progressed, precluding arterial reconstruction and requiring transtibial amputations.
Major complications directly related to CC, PTCA, and CABG were as follows: prosthetic graft infection, femoral artery pseudoaneurysms (two), sternal wound infection, renal failure, and anoxic brain injury. Treatment of all of these untoward events required operative intervention. The aortic prosthetic graft infection was treated by aortobifemoral graft removal, extra-anatomic bypass, and eventual femorodistal bypass. Neither femoral pseudoaneurysm responded to compression by ultrasound (patients were taking anticoagulants) and both eventually required operative repair. The sternal wound infection followed CABG and was treated by wound irrigation followed by construction of a myocutaneous flap; this patient spent 4 months in the intensive care unit with a total hospitalization of 236 days. One patient sustained renal failure after CABG and required permanent hemodialysis. One patient had permanent anoxic brain injury after CABG and currently resides in a long-term care facility.
Cardiac morbidity
Did intervention prevent cardiac morbidity? There were two (5%) postoperative deaths from multiorgan failure in these 42 patients. There was one MI in the 42 patients subjected to extensive cardiac evaluation for an overall rate of 2.4%. In the 34 patients who ultimately underwent the peripheral vascular operation, the MI rate was 2.9%. In contrast, in the patients not subjected to extensive cardiac workup there was an MI incidence of 2.7% and a mortality rate of 2.3% (p = NS).
Discussion
This report documents the occurrence of unfavorable outcomes in one-third of candidates for vascular surgery subjected to extensive preoperative assessment of cardiac risk over a 1-year period. Remarkably, one-fifth of the patients who were so appraised elected not to undergo the vascular procedures for which their cardiac evaluations were undertaken. Most of these individuals (seven of eight) had a Vascular Medicine 2000; 5: [3] [4] [5] [6] [7] [8] [9] potentially life-threatening vascular disorder (AAA). The reasons for refusal were multifactorial, but many patients stated something to the effect that 'they had been through enough'. This is not especially surprising considering the asymptomatic nature of the vascular and cardiac disease in some of these patients. Although there were no deaths directly attributable to cardiac workup, the morbidity was substantial, including limb loss, prosthetic graft infection, prolonged hospitalization, multiple additional operations, and even brain damage. This is a relatively small series and it may be indicted for absence of a strict protocol for determination of operative cardiac risk. However, we contend that in practice these patient scenarios are highly relevant. Most hospitals do not have an established algorithm for cardiac evaluation, and most vascular surgeons do not independently dictate the preoperative workup of their patients. Consulting servicesnotably anesthesia, cardiology, and cardiac surgery -do not necessarily appreciate the wide-ranging implications of their recommendations and interventions because multiple attending staff members interact with patients for a relatively brief period of time (i.e. during outpatient workup or in the perioperative period). In contrast, the vascular surgeon or vascular medicine specialist, who traditionally manage vascular patients over the short-and long-term, are uniquely positioned to analyze outcomes.
It is interesting that there was no difference in cardiac morbidity between the patients who had extensive evaluations/interventions compared with those who did not. This was not a randomized trial, so it is likely that the intervention group had more severe and/or symptomatic CAD than those who proceeded more directly to vascular surgery. Proponents of an aggressive approach would argue that intervention enhanced the safety of the vascular operation, avoided potential cardiac morbidity and perhaps extended the life expectancy of these patients. However, whatever the degree of this protection, it came at a high price, literally and figuratively. The charges for cardiac screening tests and procedures are difficult to determine at a VA medical center, but they are certainly substantial in the private sector.
The use of special cardiac tests and invasive interventions presupposes that cardiac morbidity can be minimized. However, determination of the frequency of adverse cardiac events after vascular surgery is not always easy. Cardiac morbidity is usually defined as the occurrence of myocardial infarction, unstable angina, congestive heart failure (CHF), serious arrhythmias, and cardiac death. Some reports have analyzed all or most of these events, while others have confined analyses to fatal and non-fatal MIs. 10, 26 Whereas these endpoints may seem straightforward, problems exist. For example, most postoperative MIs do not produce symptoms, and many are subendocardial. 41, 42 Reports are not uniform with respect to definition of MI; most investigators require two or more of the following criteria: symptoms, ECG changes and cardiac enzyme elevation, [4] [5] [6] 19, 26, 27 while others have designated enzyme changes alone. 43 Even cardiac death may be overestimated in this era of reduced autopsies. Predictably, more intensive surveillance for perioperative adverse cardiac events discloses an increased rate of cardiac complications beyond casual observation. 44 Certain series have described extremely high event rates in highly selected populations.
Pasternack and colleagues reported eight MIs in 50 highrisk patients having AAA repair -an overall incidence of 16%. 23 In contrast, Bunt has recently reported an MI rate of only 0.7% in 630 patients undergoing vascular surgery. 45 Thus, reported rates of cardiac complications vary widely.
In general, the incidence of the most serious adverse cardiac outcomes -MI and cardiac death -is relatively low. However, up to half of postoperative MIs are fatal. 42, 45 The uncommon but dangerous occurrence of postoperative MI has given rise to four major approaches to preoperative risk assessment: (1) an aggressive interventional strategy such as that evaluated by Hertzer and others in Cleveland; 12, 46 (2) a rigid protocol requiring extensive preoperative testing proposed by Bunt in Loma Linda; 45 (3) a selective evaluation recommended by several groups in Boston; 25, 27, 47 and (4) a minimalist policy championed by Taylor and colleagues in Oregon. 37 Numerous variations of these approaches have also been recommended by other authorities.
Based on our findings in the present study, we are swayed by the results Taylor et al reported using a 'minimalist' approach to preoperative cardiac screening. 37 In a 1-year period, 534 vascular procedures were performed in 491 consecutive patients. Only 5.8% of patients with severe, symptomatic CAD had studies in addition to history, physical examination, and resting ECG. Despite minimal workup, the overall MI rate was only 3.9%; MIs occurred in only 2.8% of elective cases. Potential criticisms of this economical strategy include: (1) one-fifth of the patients had previous PTCAs or CABGs; (2) patients were routinely studied for only the first 72 postoperative hours; and (3) nearly one-third of patients did not have cardiac enzymes obtained for the full 72 hours.
It is also important to consider the substantial morbidity and mortality of CABG or PTCA in elderly patients with peripheral vascular disease, many of whom also have diabetes mellitus. In the Cleveland Clinic -clearly a respected center of excellence for cardiac revascularization -266 of the 1000 consecutive vascular patients evaluated for CAD underwent prophylactic CABG: 12 of these patients died after CABG giving a mortality rate of 4.5%. 12 Cutler and Leppo screened 116 patients scheduled for peripheral vascular operations with DTSs and referred seven (6%) for CABG. 26 One patient died after CABG (14%) and another died awaiting CABG (14%). No operative deaths occurred after the subsequent 106 peripheral vascular operations; thus, the two deaths that occurred (1.9%) were directly related to the cardiac screening program. Even 'less invasive' PTCA carries substantial risk in the diabetic population that has a high prevalence of vascular disease. Kip and colleagues compared short-and long-term outcomes of PTCA in 281 diabetic and 1833 non-diabetic patients in the multicenter National Heart, Lung, and Blood Institute PTCA Registry. 48 Nine-year mortality was twice as high in diabetic patients (35.9% versus 17.9%), with non-fatal MI rates of 29.0% versus 18.5%, respectively. In the small series reported by Huber et al from the Mayo Clinic, 50 patients were identified as high risk for cardiac morbidity before vascular surgery; despite prophylactic PTCA, the incidence of perioperative non-fatal and fatal MIs was 5.6% and 1.9%, respectively. 36 Results of the present study emphasize the effect of prolonged cardiac evaluation on patient consent and/or medical Vascular Medicine 2000; 5: [3] [4] [5] [6] [7] [8] [9] stability for eventual vascular surgery. Several patients with large AAAs had surgery delayed extensively while they recovered from cardiac interventions, while others refused surgery altogether. One patient who refused an operation remains at risk for stroke from symptomatic carotid stenosis. Admittedly, our VA population may not be equivalent to patients in the private sector, especially with respect to the time required for cardiac evaluation. The large geographic area served by the Denver VAMC contributes to scheduling difficulties for outpatient evaluations. However, the random requests of consulting services for cardiac studies and interventions are not necessarily in the patient's best interests -especially in this era of managed and capitated medical care. Reports supporting prophylactic CAD intervention are non-randomized and uncontrolled. 12, [32] [33] [34] [35] [36] Proponents of a minimalist approach to preoperative cardiac evaluation have achieved cardiac morbidity rates comparable with advocates of more aggressive strategies. A recent decision analysis using sophisticated computerized analytic methods has corroborated the contention that proceeding directly to vascular surgery leads to decreased morbidity and lower costs than routine extensive evaluations. 49 Optimal protocols and management guidelines ideally should arise from randomized controlled studies. Properly designed randomized trials must be instituted to confirm the value of invasive, expensive, and potentially dangerous interventions. A Department of Veterans Affairs Cooperative Trial (Coronary Artery Revascularization Prophylaxis -CARP) to investigate this issue has recently been initiated, but results will not be forthcoming for many years. Until then, we recommend extended cardiac evaluation and intervention only when the patient's cardiac symptoms warrant treatment, not to enhance safety of the proposed vascular procedure, because advances in surgical and anesthetic techniques and intra-and postoperative monitoring have reduced the morbidity and mortality of elective vascular surgery. We feel that cardiac screening tests are most useful to avoid operations in patients with less compelling indications (e.g. smaller AAAs, asymptomatic carotid stenoses, claudication), or to alter operative strategies to favor lower risk options when possible (e.g. axillobifemoral vs aortobifemoral bypasses). At present, we recommend a minimalist approach for the cardiac evaluation of patients with 'mandatory' indications for vascular reconstruction and a selective approach for those with 'relative' indications. 
